General Commentary
Accepted on 14 May 2026
Commentary: Rituximab combined with lenalidomide for the treatment of marginal zone lymphoma with IgM kappa positivity and cold agglutinin syndrome: a case report
in Cancer Immunity and Immunotherapy
General Commentary
Accepted on 14 May 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 14 May 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 14 May 2026
in B Cell Biology
Systematic Review
Accepted on 14 May 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 14 May 2026
in Special Educational Needs
Original Research
Accepted on 14 May 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 14 May 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 14 May 2026
in Head and Neck Cancer
Original Research
Accepted on 14 May 2026
in Translational Medicine
Original Research
Accepted on 14 May 2026
in Pharmacology of Anti-Cancer Drugs
Case Report
Accepted on 14 May 2026
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 14 May 2026
in Breast Cancer
Original Research
Accepted on 14 May 2026
in Educational Psychology
Original Research
Accepted on 14 May 2026
in Veterinary Pharmacology and Toxicology
Original Research
Accepted on 14 May 2026
in Parkinson’s Disease and Aging-related Movement Disorders
Original Research
Accepted on 14 May 2026
in Intensive Care Medicine and Anesthesiology